Aerie Pharmaceuticals, Inc. Gains 35.96%

Tue, Aug 23, 2022 at 07:02 PM
Aerie Pharmaceuticals, Inc. Gains 35.96%

Aerie Pharmaceuticals, Inc. (AERI:NASDAQ) jumped higher at $15.16, a gain of 36%. On Tue, Aug 23, 2022, AERI:NASDAQ hit a New 2-Week High of $15.16. The stock appeared on our News Catalysts scanner on Tue, Aug 23, 2022 at 05:11 PM in the 'ACQUISITION' category. From Tue, Aug 09, 2022, the stock recorded 60.00% Up Days and 63.64% Green Days

About Aerie Pharmaceuticals, Inc. (AERI:NASDAQ)

Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is engaged in the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.